Clinical Trial Update: Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing letrozole to anastrozole as adjuvant therapy in postmenopausal women with hormone receptor–positive, node-positive breast cancer; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Letrozole (letrozole)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-10-09